news
Combination therapy suppresses HIV-like virus in primates
Broadly neutralising antibody treatment may target viral reservoir in monkeys...
List view / Grid view
HIV (Human Immunodeficiency Virus)
news
Biktarvy approved for the treatment of HIV-1 infection
The FDA has approved Biktarvy a once-daily single-tablet regimen for the treatment of HIV-1 infection...
news
Robotic method isolates high-producing cell lines for HIV vaccine production
Technical advances in vaccine production should shorten the time to clinical trials, breaking the logjam of promising new candidate vaccines waiting to be tested...
news
NIH begins large HIV treatment study in pregnant women
Clinical trial will compare three antiretroviral drug regimens...
news
Drug capsule may allow weekly HIV treatment
Replacing daily pills with a weekly regimen could help patients stick to their dosing schedule...
news
HIV epidemic on track to be controlled by 2020
Data released from the U.S. President's Emergency Plan for AIDS Relief has shown that the HIV epidemic is coming under control...
news
Cancer drug can reactivate HIV
A team of scientists have recently discovered how a new drug called JQ1 which is currently in early-phase human cancer trials, can reactivate latent HIV...
news
BIOCAD does its sums for growth
Russian biotech company BIOCAD plans to leverage competitive advantages to take 5% of the European medicines market
news
Gilead’s fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability
Phase 3 trials of Gilead’s fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability and low resistance
news
Low-cost drugs package saves lives of people starting HIV treatment late
Treating people who start HIV treatment late with a package of low-cost drugs to prevent serious infections saves three lives for ...
news
Gilead submits drug application to FDA for HIV treatment
Gilead has submitted a new drug application to the US FDA for treatments of HIV.
news
ViiV Healthcare submits regulatory applications for HIV two-drug regimen
6 June 2017 | By Niamh Marriott, Junior Editor
Regulatory submissions to the EMA and FDA for a single-tablet, two-drug regimen of dolutegravir & rilpivirine for the maintenance treatment of HIV...
news
A path toward ending AIDS epidemic in the US by 2025
15 May 2017 | By Niamh Marriott, Junior Editor
A new study describes an ambitious but feasible path toward what may have seemed unachievable just a decade ago: an end to the AIDS epidemic in the US...
news
The continuum of HIV care: What does it mean and how is Europe doing?
12 May 2017 | By Niamh Marriott, Junior Editor
From diagnosis of HIV to successful viral suppression: this new ECDC report summarises key findings concerning and the Continuum of HIV Care in Europe...
news
First ever evidence of treatment-induced reduction in HIV reservoirs
4 May 2017 | By Niamh Marriott, Junior Editor
Abivax’s lead therapeutic candidate ABX464 demonstrated the first reduction in HIV reservoirs ever observed in chronically infected HIV patients...
